Q32 Bio Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Jodie Morrison
Chief executive officer
US$1.1m
Total compensation
| CEO salary percentage | 48.8% |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 1.1yrs |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$61m |
| Jun 30 2024 | n/a | n/a | -US$57m |
| Mar 31 2024 | n/a | n/a | -US$46m |
| Dec 31 2023 | US$1m | US$525k | -US$54m |
| Sep 30 2023 | n/a | n/a | -US$36m |
| Dec 31 2022 | US$2m | US$120k | -US$43m |
Compensation vs Market: Jodie's total compensation ($USD1.08M) is above average for companies of similar size in the UK market ($USD736.76K).
Compensation vs Earnings: Jodie's compensation has been consistent with company performance over the past year.
CEO
Jodie Morrison (48 yo)
less than a year
Tenure
US$1,075,907
Compensation
Ms. Jodie Pope Morrison is Director of Verve Therapeutics, Inc. from June 2024. Ms. Jodie Pope Morrison serves as Chief Executive Officer and Director of Q32 Bio Inc. since March 2024. Ms. Morrison previou...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$1.08m | no data | |
| Co-founder | 7.2yrs | US$716.22k | 0.49% $ 1.5m | |
| Chief Medical Officer | less than a year | US$680.93k | 0% $ 0 | |
| CFO & President | less than a year | no data | 0% $ 0 | |
| Chief Technology Officer | 1.1yrs | no data | no data | |
| Senior VP & Head of People | 2.2yrs | no data | no data | |
| Executive Vice President of Corporate Strategy & Program Operations | 1.8yrs | no data | no data | |
| Head of Chemistry | no data | no data | no data |
1.1yrs
Average Tenure
52.5yo
Average Age
Experienced Management: 0T6G's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | less than a year | US$1.08m | no data | |
| Independent Director | less than a year | US$40.00k | 0.045% $ 133.3k | |
| Independent Director | less than a year | no data | 0% $ 0 | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | less than a year | US$50.00k | 0% $ 0 | |
| Independent Director | less than a year | US$40.00k | 0.0098% $ 29.5k | |
| Independent Director | less than a year | no data | no data | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | 2.8yrs | no data | no data |
0.7yrs
Average Tenure
57yo
Average Age
Experienced Board: 0T6G's board of directors are not considered experienced ( 0.7 years average tenure), which suggests a new board.